15.05.2006 05:00:00
|
Genesys Conferencing Reports First Quarter Results for 2006
In the first quarter of 2006, revenue(1) increased 6.6% to EUR36.4 million, compared to revenue of EUR 34.1 million in the firstquarter of 2005. In U.S. dollars, revenue was USD 43.7 millioncompared to USD 44.8 million in the first quarter of 2005. Totalvolume increased 19.0% to 552.2 million minutes. Genesys MeetingCenter volume increased 21.1% to 517.8 million minutes of which over50% was generated under the Multimedia Minute program.
"Volume continues to grow at significant levels and we haveabsorbed the impact from the loss of a major customer in the fourthquarter of 2005," said Francois Legros, Chairman and Chief ExecutiveOfficer. "We are very pleased with the effectiveness of the MultimediaMinute program in helping to drive customer adoption of our servicesas a core, enterprise-wide application. Additionally, we are excitedabout the new Genesys VoIP services which will be available forenterprise deployment later in 2006."
Gross margin for the first quarter of 2006 was 63.3% down from64.0% in the first quarter of 2005. The expected decline is largely aresult of the major customer loss in the fourth quarter of 2005 whichon average accounted for a higher level of direct contribution. Grossprofit for the first quarter of 2006 was EUR 23.0 million compared toEUR 21.8 million in the first quarter of 2005. The increase is theresult of year-over-year revenue growth.
Selling, general and administrative expenses were EUR 20.5 millionin the first quarter of 2006, up EUR 2.6 million, or 14.5%, comparedto EUR 17.9 million in the first quarter of 2005. The change is thenet result of a EUR 2.3 increase in selling and marketing expenses anda EUR 0.6 million increase in research and development expenses,offset by a EUR 0.3 million one-time restructuring charge that wasrecorded in the first quarter of 2005. The increase in selling andmarketing expenses continues to reflect the initiatives begun in thesecond quarter of 2005 to expand efforts targeted towards the largeenterprise market and the greater adoption of the Multimedia Minuteprogram. The increase in research and development expenses relates tothe company's development of VoIP conferencing functionalities whichinclude a Genesys soft-phone technology that is presently beingintroduced in a beta test phase to several large customers. Researchand development expenses also include efforts related to the company'sdevelopment of a next generation IP collaboration platform that isexpected to be introduced later in 2006. In the first quarter of 2006,general and administrative expenses were EUR 7.8 million andconsistent with spending levels in the first quarter of 2005.
Earnings before interest, taxes, depreciation and amortization(EBITDA(2)) and before stock-based compensation expenses were EUR 4.8million for the first quarter 2006, a 13.2% EBITDA margin compared toEUR 6.3 million and 18.7%, respectively, for the first quarter of2005. Stock-based compensation expenses were EUR 0.3 million and EUR0.3 million for the first quarters of 2006 and 2005, respectively. Thedecline in EBITDA primarily reflects the company's furtherreinvestment in sales and technology development.
Earnings before interest and taxes (EBIT) declined to EUR 1.7million in the first quarter of 2006 from EUR 3.2 million in the firstquarter of 2005. The company reported a net loss of EUR (0.7) millionfor the first quarter of 2006 compared to net income of EUR 1.5million in the first quarter of 2005. The net loss this quarter ispartially due to non-cash charges of approximately EUR 0.8 millionwhich include a EUR 0.5 million provision for deferred income taxexpense (see Income Taxes note below).
Liquidity
As previously announced, the company successfully completed onFebruary 22, 2006, a EUR 53.6 million equity offering, the proceeds ofwhich were used to repay a majority of its outstanding debt. As aresult of this recapitalization, the company's net debt as of March31, 2006 improved to EUR 28.6 million and its shareholders' equityimproved to EUR 37.2 million compared to EUR 72.0 million and EUR(8.3) million as of December 31, 2005, respectively. As of March 31,2006, the company's net cash(3) was EUR 3.8 million.
Guidance
The following contains forward-looking guidance regarding Genesys'financial outlook and is based on current expectations and a fixedcurrency rate of exchange of EUR 1.00 = USD 1.25, similar to theaverage exchange rate for 2005. Actual results may differ materially,and the company may not update any forward-looking statements made inthis press release.
In line with its previously issued financial outlook for 2006revenue and EBITDA, excluding stock-based compensation, the companyexpects that its full-year 2006 net income will be positive despitethe additional non-cash, deferred income tax expense that is exceptedto impact 2006 results.
Conference Call and Webcast
Chairman and Chief Executive Officer Francois Legros and ExecutiveVice President/Chief Financial Officer Michael E. Savage will host aconference call on Monday, May 15, 2006, at 5:30 p.m. Central EuropeanTime or 11:30 a.m. Eastern Time to discuss first quarter 2006financial results.
The conference call will be web cast live and may be accessed at:http://events.webeventservices.com/genesys/2006/05/15/
A replay of the call will be available at http://www.genesys.com
(1) Please refer to the paragraph "Impact of Exchange Rates" below for information regarding the calculation of U.S. Dollar amounts.
(2) See attached note to consolidated statements of operations for reconciliation of Operating Income and EBITDA. The company believes that EBITDA is a meaningful measure of performance, because it presents the company's results of operations without the non-cash impact of depreciation and amortization. EBITDA is reported excluding stock-based compensation expense.
(3) Cash includes cash and cash equivalents less bank overdrafts.
Income Taxes
Subsequent to its prior release of unaudited financial statementsunder International Financial Reporting Standards for the year endedDecember 31, 2005, on April 5, 2006, based on the historical earningsand projected income related to its Canadian subsidiary, managementhas concluded it is more likely than not that it will fully benefitfrom its Canadian net operating losses.
Accordingly, at December 31, 2005, the Company reduced itsvaluation allowance against deferred tax assets generated in Canada.Such reduction in valuation allowance reduced its provision for incometax expense by approximately EUR 1.9 million in 2005. Additionally, in2006, as the Company realizes the benefits of net operating lossescarried forward, it will recognize a non-cash provision for deferredincome tax expense.
Adoption of International Financial Reporting Standards
Effective in 2005, the Company, like all public companiesorganized in France and other European Union countries, adopted thenew International Financial Reporting Standards (IFRS) for reportingof its financial results. The Company previously reported under FrenchGAAP.
At present, established practice in forming opinions regardinginterpretation and application of IFRS continues to evolve. Based uponits final review, the company has determined that deferred taxliabilities arising from previous acquisitions should be de-recognizedin its opening balance sheet at January 1, 2004 under IFRS. Thismodification primarily results in a net increase in equity of EUR 4.5million, a reduction of deferred tax liabilities of EUR 3.6 millionand a EUR 0.9 million non-cash increase in provision for income taxesas of and for the year ended December 31, 2005.
The company is not aware of any additional modifications that arenecessary in connection with the application of IFRS.
Impact of Exchange Rates
The company serves large enterprises on a worldwide basis. As aresult, the company has extensive international operations and, thus,significant exposure to exchange rate fluctuations, in particularthose of the U.S. dollar. In 2003, the U.S. dollar declinedsignificantly compared to the euro, and its value further fluctuatedduring 2004 and 2005. As a result, the comparability of the company'srevenues and results of operations expressed in euros weresignificantly impacted.
The company prepares its consolidated financial statements ineuros. In order to demonstrate the impact of the volatility of theU.S. dollar on its revenues from the first quarter of 2005 to thefirst quarter of 2006, the company has recalculated its revenues as ifits functional currency had been the U.S. dollar rather than the euro.For this purpose, the company has used the average for each quarter of2005 and 2006 of the daily euro/U.S. dollar exchange rate which arethe rates it uses for translation purposes in its consolidated incomestatement.
Forward-Looking Statements
This release contains statements that constitute forward-lookingstatements within the meaning of the U.S. Private SecuritiesLitigation Reform Act of 1995. Forward-looking statements arestatements other than historical information or statements of currentcondition. These statements appear in a number of places in thisrelease and include statements concerning the parties' intent, beliefor current expectations regarding future events and trends affectingthe parties' financial condition or results of operations.
Forward-looking statements are not guarantees of futureperformance and involve risks and uncertainties, and actual resultsmay differ materially from those in the forward-looking statements asa result of various factors. Some of these factors are described inthe Form 20-F that was filed by Genesys with the Securities andExchange Commission on May 2, 2005.
Although management of the parties believe that their expectationsreflected in the forward-looking statements are reasonable based oninformation currently available to them, they cannot assure you thatthe expectations will prove to have been correct. Accordingly, youshould not place undue reliance on these forward-looking statements.In any event, these statements speak only as of the date of thisrelease. Except to the extent required by law, the parties undertakeno obligation to revise or update any of them to reflect events orcircumstances after the date of this release, or to reflect newinformation or the occurrence of unanticipated events.
About Genesys Conferencing
Genesys Conferencing is a leading provider of integrated Web,audio and video conferencing services to thousands of organizationsworldwide, including more than 200 of the Fortune Global 500. Thecompany's services are designed to meet the full range ofcommunication needs within the large enterprise, from collaborativeteam meetings to high-profile online events. The company's flagshipproduct, Genesys Meeting Center, provides a single-platform multimediaconferencing solution that is easy to use and available on demand.With offices in more than 20 countries across North America, Europeand Asia Pacific, the company offers an unmatched global presence andstrong local support. Genesys Conferencing is publicly traded onEuronext Eurolist in France (ISIN FR0004270270) and on the Nasdaq inthe U.S. (GNSY). Additional information is available atwww.genesys.com.
GENESYS CONFERENCING
Consolidated Balance Sheets
(Unaudited, in thousands of euros, except share data)
December 31, March 31,
2005 2006
------------ ------------
IFRS IFRS
--------------------------
ASSETS
Fixed assets
Goodwill, customer lists and technology 33,330 35,780
Other intangible assets, net 5,662 5,914
Tangible assets, net 16,011 15,842
Financial assets, net 1,894 2,159
Deferred tax assets 2,489 1,899
Investments in affiliated companies 278 -
------------ ------------
Total non current assets 59,664 61,594
Current assets
Accounts receivable, less allowances (EUR
1,547 and EUR 1,303 at December 31,
2005 and March 31, 2006, respectively) 27,692 29,169
Deferred tax assets 724 841
Other current assets 7,529 8,653
Marketable securities 35 32
Cash at bank 5,879 5,557
------------ ------------
Total current assets 41,859 44,252
------------ ------------
TOTAL ASSETS 101,523 105,846
============ ============
LIABILITIES AND SHAREHOLDERS' EQUITY
(DEFICIT)
Shareholders' equity (deficit)
Ordinary shares, nominal value of EUR 1
per share 18,307,756 shares issued and
outstanding at December 31, 2005 and
69,798,286 shares issued and
outstanding at March 31, 2006 18,308 69,798
Common shares to be issued 139 139
Additional paid-in capital 185,080 179,885
Additional paid-in capital to be issued 3,831 3,831
Reserve for Stock-based compensation 2,605 2,898
Accumulated deficit (223,429) (218,885)
Net income (loss) for the period 4,544 (734)
Currency translation adjustments 668 263
------------ ------------
Total shareholders' equity (deficit) (8,254) 37,195
Provisions for risks and charges 720 524
Deferred tax liabilities 59 59
Long-term debt
Long-term portion of long-term debt 62,474 30,607
Long-term portion of capitalized lease
obligations 39 32
------------ ------------
Total long-term debt 63,292 31,222
Current liabilities
Bank overdrafts 1,851 1,766
Accounts payable and accrued liabilities 13,254 15,876
Other taxes payable and deferred
compensation 9,493 10,789
Income taxes payable 3,147 2,334
Current portion of provision for risks
and charges 908 896
Current portion of long-term debt 13,483 1,745
Current portion of capitalized lease
obligations 4 5
Other current liabilities 4,345 4,018
------------ ------------
Total current liabilities 46,485 37,429
------------ ------------
LIABILITIES AND SHAREHOLDERS' EQUITY 101,523 105,846
============ ============
GENESYS CONFERENCING
Consolidated Statements of Operations
(Unaudited, in thousands of euros, except share data)
Three months ended March 31,
----------------------------
IFRS IFRS
-------------- -------------
2005 2006
-------------- -------------
Revenue
Services 34,122 36,377
-------------- -------------
Cost of Revenue
Services 12,289 13,357
-------------- -------------
Gross Profit 21,833 23,020
Operating expenses
Research and development 650 1,203
Selling and marketing 9,202 11,495
General and administrative 7,771 7,847
Restructuring charge 326 -
Amortization of intangibles 698 747
-------------- -------------
18,647 21,292
-------------- -------------
Operating income 3,186 1,728
Financial expense, net (1,755) (1,094)
Equity in income of affiliated companies 4 -
Income tax credit (expense) 19 (1,368)
-------------- -------------
Net income (loss) 1,454 (734)
-------------- -------------
Basic and diluted net income (loss) per
share 0.08 (0.02)
============== =============
Number of outstanding shares used in
computing basic and diluted net income
(loss) per share 18,372,841 40,186,897
GENESYS CONFERENCING
Notes to the Consolidated Financial Statements
(Unaudited, in thousands of euros)
Three months ended March 31,
----------------------------
IFRS IFRS
-------------- -------------
NOTE A- EBITDA calculation 2005 2006
-------------- -------------
Operating income 3,186 1,728
Amortization of identifiable intangible
assets 698 747
Depreciation 2,175 2,048
-------------- -------------
EBITDA (2) 6,059 4,523
-------------- -------------
Stock-based compensation 306 293
EBITDA before stock-based compensation 6,365 4,816
============== =============
Three months ended March 31,
----------------------------
IFRS IFRS
-------------- -------------
NOTE B- DETAIL OF FINANCIAL INCOME
(EXPENSE), NET 2005 2006
-------------- -------------
Interest and other financial income 313 201
Foreign exchange gains 558 3,756
-------------- -------------
Total financial income 871 3,957
Interest and other financial expenses (2,261) (1,858)
Foreign exchange losses (365) (3,193)
-------------- -------------
Total financial charges (2,626) (5,051)
Financial expense, net (1,755) (1,094)
============== =============
Three months ended March 31,
----------------------------
IFRS IFRS
-------------- -------------
NOTE C - DETAIL OF INCOME TAX EXPENSE 2005 2006
-------------- -------------
Deferred tax credit (expense) - (551)
Income tax credit (expense) 19 (817)
-------------- -------------
Total income tax credit (expense) 19 (1,368)
============== =============
At December 31, At March 31,
--------------- ------------
NOTE D - DETAIL OF ACCOUNTS RECEIVABLE,
NET IFRS IFRS
--------------- ------------
2005 2006
--------------- ------------
Billed portion of accounts receivable,
net 21,332 19,019
Unbilled portion of accounts receivable,
net 6,360 10,150
--------------- ------------
Total accounts receivable, net 27,692 29,169
=============== ============
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Genesys S.A.mehr Nachrichten
Keine Nachrichten verfügbar. |